@Article{Maciów-Głąb2017,
journal="Archiwum Medycyny Sądowej i  Kryminologii/Archives of Forensic Medicine and Criminology",
issn="0324-8267",
year="2017",
title="New psychoactive substances in substantive evidence in expert practice of the Department of Forensic Medicine, UJCM in the years 2010–2015",
abstract=" Aim of the study  was to analyse of 2075 evidences containing new psychoactive substances (NPS).   Material and methods : The prepared samples were identified employing an analytical procedure where the analytes were investigated by gas chromatography-electron impact mass spectrometry (GC-EI-MS) using a created library of mass spectra.   Results : The analysis revealed the following substances in the investigated products: piperazine derivatives (including BZP, MPMP, TFMPP), cathinone derivatives (including: pentedrone, 3-MMC, butylone, 4-MEC), pyrovalerone derivatives (MDPV, naphyrone, α-PVP, α-PVT), synthetic cannabinoids (such as AM-2201, UR-144, XLR-11, JWH073, JWH081, PB-22, AB-CHMINACA). Research conducted in 2010–2015 made it possible to track changes in the composition of investigated preparations.   Conclusions : The following relationships has been shown: number of components decreased and in the end of 2015 dominated preparations with single component; introduction of amendments Act on Preventing Drug Addictionn affect the elimination from the market of one compounds and replacing them by their derivatives; since 2011 on the market of ‘legal highs’ we did not observe occurrence of compounds of piperazine group.",
author="Maciów-Głąb, Martyna
and Kula, Karol
and Kłys, Małgorzata
and Rojek, Sebastian D.",
pages="178--200",
doi="10.5114/amsik.2017.71449",
url="http://dx.doi.org/10.5114/amsik.2017.71449"
}